These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 18977178

  • 1. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P, Rauck R, Tobias J, NGX-4010 C116 Study Group.
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [Abstract] [Full Text] [Related]

  • 2. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.
    Backonja MM, Malan TP, Vanhove GF, Tobias JK, C102/106 Study Group.
    Pain Med; 2010 Apr; 11(4):600-8. PubMed ID: 20113411
    [Abstract] [Full Text] [Related]

  • 3. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR, Tark M, Rauck R, Tobias JK, Vanhove GF.
    BMC Neurol; 2010 Oct 11; 10():92. PubMed ID: 20937130
    [Abstract] [Full Text] [Related]

  • 4. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
    Irving G, Backonja M, Rauck R, Webster LR, Tobias JK, Vanhove GF.
    Clin J Pain; 2012 Feb 11; 28(2):101-7. PubMed ID: 21753727
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Webster LR, Malan TP, Tuchman MM, Mollen MD, Tobias JK, Vanhove GF.
    J Pain; 2010 Oct 11; 11(10):972-82. PubMed ID: 20655809
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
    Simpson DM, Gazda S, Brown S, Webster LR, Lu SP, Tobias JK, Vanhove GF, NGX-4010 C118 Study Group.
    J Pain Symptom Manage; 2010 Jun 11; 39(6):1053-64. PubMed ID: 20538187
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J, NGX-4010 C117 Study Group.
    Pain Med; 2011 Jan 11; 12(1):99-109. PubMed ID: 21087403
    [Abstract] [Full Text] [Related]

  • 8. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
    Simpson DM, Brown S, Tobias JK, Vanhove GF, NGX-4010 C107 Study Group.
    Clin J Pain; 2014 Feb 11; 30(2):134-42. PubMed ID: 23446088
    [Abstract] [Full Text] [Related]

  • 9. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
    Simpson DM, Estanislao L, Brown SJ, Sampson J.
    J Pain Symptom Manage; 2008 Mar 11; 35(3):299-306. PubMed ID: 17959343
    [Abstract] [Full Text] [Related]

  • 10. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM, Moore KA, Peterson DM.
    J Pain Palliat Care Pharmacother; 2011 Mar 11; 25(1):32-41. PubMed ID: 21426216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C, Poole CD, Ernault E, Thomas R, Berni E, Currie CJ, Treadwell C, Calvo JI, Plastira C, Zafeiropoulou E, Odeyemi I.
    BMC Neurol; 2017 Apr 21; 17(1):80. PubMed ID: 28431564
    [Abstract] [Full Text] [Related]

  • 14. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP.
    Clin J Pain; 2014 Apr 21; 30(4):286-94. PubMed ID: 23765045
    [Abstract] [Full Text] [Related]

  • 15. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S, Sven-Rice A, Cole P, Tan T, Moore RA.
    Cochrane Database Syst Rev; 2013 Feb 28; (2):CD007393. PubMed ID: 23450576
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
    Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GF, NGX-4010 C119 Study Group.
    J Acquir Immune Defic Syndr; 2012 Feb 01; 59(2):126-33. PubMed ID: 22067661
    [Abstract] [Full Text] [Related]

  • 17. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP, Mou J, Paillard FC, Turnbull B, Trudeau J, Stoker M.
    Clin J Pain; 2015 Oct 01; 31(10):859-66. PubMed ID: 25503598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
    Webster LR, Peppin JF, Murphy FT, Lu B, Tobias JK, Vanhove GF.
    Diabetes Res Clin Pract; 2011 Aug 01; 93(2):187-197. PubMed ID: 21612836
    [Abstract] [Full Text] [Related]

  • 20. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
    Maihofner C, Heskamp ML.
    Curr Med Res Opin; 2013 Jun 01; 29(6):673-83. PubMed ID: 23551064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.